{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:36Z","timestamp":1747181196288,"version":"3.40.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,29]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Lynch syndrome is caused by germline mutations of DNA mismatch repair genes. A significant risk increase for several types of cancer is one of the characteristics of lynch syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 45-year-old female presented to the emergency department with abdominal pain that had persisted for a month.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The abdominal and pelvic computed tomography scan showed edematous and thickening of the proximal small bowel wall, as well as dilatation of the proximal bowel and stomach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Tumor resection of the small bowel was performed, and adenocarcinoma was confirmed pathologically. Microsatellite instability was also confirmed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Postoperative imaging revealed soft tissue lesions with potential for tumor seeding. Two months after the first surgery, a secondary surgery was performed as a result of cancer recurrence. The patient received chemotherapy with capecitabine. The latest computed tomography scan, performed 19 months after the cessation of chemotherapy, did not show any recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In the rare incidence of small bowel cancer genetic mutation testing and detailed family history should be actively considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000035323","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T17:11:25Z","timestamp":1696007485000},"page":"e35323","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Small intestinal adenocarcinoma accompanied by lynch syndrome: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Kyoung Won","family":"Yoon","sequence":"first","affiliation":[{"name":"Division of Critical Care, Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaemin","family":"Jo","sequence":"additional","affiliation":[{"name":"Division of Hemato-Oncology, Department of Internal Medicine, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-2663","authenticated-orcid":false,"given":"Donghyoun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Jeju National University Hospital, Jeju National University College of Medicine, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1158\/1078-0432.CCR-21-0159","article-title":"ZEBRA: a multicenter phase II study of Pembrolizumab in patients with advanced small-bowel adenocarcinoma.","volume":"27","author":"Pedersen","year":"2021","journal-title":"Clin Cancer Res"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer.","volume":"348","author":"Lynch","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","article-title":"Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.","volume":"75","author":"Barrow","year":"2009","journal-title":"Clin Genet"},{"issue":"11 Pt 1","key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1158\/1078-0432.CCR-05-2452","article-title":"Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study.","volume":"12","author":"Park","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"21483","DOI":"10.18632\/oncotarget.15277","article-title":"Lynch syndrome-related small intestinal adenocarcinomas.","volume":"8","author":"Jun","year":"2017","journal-title":"Oncotarget"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3816\/CCC.2004.n.023","article-title":"Small bowel adenocarcinoma: a rare but aggressive disease.","volume":"4","author":"Delaunoit","year":"2004","journal-title":"Clin Colorectal Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/cancers11010031","article-title":"Small bowel carcinomas associated with immune-mediated intestinal disorders: the current knowledge.","volume":"11","author":"Giuffrida","year":"2018","journal-title":"Cancers (Basel)"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dld.2013.04.013","article-title":"Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment.","volume":"46","author":"Aparicio","year":"2014","journal-title":"Dig Liver Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000355210","article-title":"Small bowel neoplasias: current options for diagnosis, staging and therapeutic management.","volume":"1","author":"Fry","year":"2014","journal-title":"Gastrointestinal Tumors"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(08)70232-8","article-title":"Small-bowel cancer in Lynch syndrome: is it time for surveillance?","volume":"9","author":"Koornstra","year":"2008","journal-title":"Lancet Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12029-017-9991-0","article-title":"Expending role of microsatellite instability in diagnosis and treatment of colorectal cancers.","volume":"48","author":"Chang","year":"2017","journal-title":"J Gastrointest Cancer"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/02841860903490051","article-title":"Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.","volume":"49","author":"Overman","year":"2010","journal-title":"Acta Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12957-022-02549-7","article-title":"Clinical benefits of PD-1\/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis.","volume":"20","author":"Zhang","year":"2022","journal-title":"World J Surg Oncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejca.2014.10.027","article-title":"Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.","volume":"51","author":"Bogaerts","year":"2015","journal-title":"Eur J Cancer"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jjco\/hyy188","article-title":"Randomized phase III trial of post-operative chemotherapy for patients with stage I\/II\/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD).","volume":"49","author":"Kitahara","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:39:41Z","timestamp":1746326381000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":17,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035323","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}